Kailee Rainse / startuprise - Biotech firm Nuclera has raised an additional $12 million increasing its total Series C funding to $87 million. The extension round was led by Elevage Medical Technologies and Jonathan Milner with participation from existing investors including British Bu…
Back to Top / Tuesday, January 13, 2026, 6:21 am / permalink 17824 / 5 stories in 7 wks
Eli Lilly to acquire Orna Therapeutics in a $2.4B biotech deal / 25 days
IVFmicro secures £3.5M to boost IVF treatment technology / 2 months
Nobel Prize honors breakthroughs in immune tolerance research / 5 months
Bedfordshire biotech Tozaro raises funding to scale gene-therapy platform / 18 days
FluoSphera secures seed funding for 3D organ model innovation / 7 wks
Amgen acquires Oxford’s Dark Blue Therapeutics in major biotech deal / 1 month
Outpost Bio lands $3.5M to turn the microbiome into predictive AI infrastructure / 4 days
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.